These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 14697460)

  • 1. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality.
    Kini AS; Lee P; Marmur JD; Agarwal A; Duffy ME; Kim MC; Sharma SK
    Am J Cardiol; 2004 Jan; 93(1):18-23. PubMed ID: 14697460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of creatine kinase-MB elevation after percutaneous coronary intervention in patients with chronic renal dysfunction.
    Jeremias A; Albirini A; Ziada KM; Chew DP; Brener SJ; Topol EJ; Ellis SG
    Am Heart J; 2002 Jun; 143(6):1040-5. PubMed ID: 12075261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention.
    Nageh T; Sherwood RA; Harris BM; Byrne JA; Thomas MR
    Int J Cardiol; 2003 Dec; 92(2-3):285-93. PubMed ID: 14659867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different?
    Akkerhuis KM; Alexander JH; Tardiff BE; Boersma E; Harrington RA; Lincoff AM; Simoons ML
    Circulation; 2002 Feb; 105(5):554-6. PubMed ID: 11827918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of cardiac troponin I re-elevation following percutaneous coronary intervention in high-risk patients with acute coronary syndromes.
    Fuchs S; Gruberg L; Singh S; Stabile E; Duncan C; Wu H; Waksman R; Satler LF; Pichard AD; Kent KM; Kornowski R
    Am J Cardiol; 2001 Jul; 88(2):129-33. PubMed ID: 11448408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Troponin I elevation and cardiac events after percutaneous coronary intervention.
    Ricciardi MJ; Davidson CJ; Gubernikoff G; Beohar N; Eckman LJ; Parker MA; Bonow RO
    Am Heart J; 2003 Mar; 145(3):522-8. PubMed ID: 12660677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Ndrepepa G; Colleran R; Braun S; Xhepa E; Hieber J; Cassese S; Fusaro M; Kufner S; Laugwitz KL; Schunkert H; Kastrati A
    Catheter Cardiovasc Interv; 2018 Feb; 91(2):215-223. PubMed ID: 28500730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of cardiac troponin I elevation after percutaneous coronary intervention in patients with chronic renal insufficiency: a 12-month outcome analysis.
    Gruberg L; Fuchs S; Waksman R; Pichard AD; Kent KM; Laird JR; Wu H; Elsayyad S; Allen CM; Satler LF
    Catheter Cardiovasc Interv; 2002 Feb; 55(2):174-9. PubMed ID: 11835642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Chia S; Senatore F; Raffel OC; Lee H; Wackers FJ; Jang IK
    JACC Cardiovasc Interv; 2008 Aug; 1(4):415-23. PubMed ID: 19463339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creatine kinase-MB fraction elevation after percutaneous coronary intervention in patients with chronic renal failure.
    Gruberg L; Mehran R; Waksman R; Dangas G; Fuchs S; Wu H; Kent KM; Pichard AD; Satler LF; Stone GW; Leon MB
    Am J Cardiol; 2001 Jun; 87(12):1356-60. PubMed ID: 11397353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study.
    Cavallini C; Savonitto S; Violini R; Arraiz G; Plebani M; Olivari Z; Rubartelli P; Battaglia S; Niccoli L; Steffenino G; Ardissino D;
    Eur Heart J; 2005 Aug; 26(15):1494-8. PubMed ID: 15741227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: systematic monitoring of the three markers of myocardial necrosis.
    Varani E; Balducelli M; Vecchi G; Gatti C; Lucchi GR; Maresta A
    J Interv Cardiol; 2005 Aug; 18(4):243-8. PubMed ID: 16115152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of elevated troponin I after percutaneous coronary intervention.
    Cantor WJ; Newby LK; Christenson RH; Tuttle RH; Hasselblad V; Armstrong PW; Moliterno DJ; Califf RM; Topol EJ; Ohman EM;
    J Am Coll Cardiol; 2002 Jun; 39(11):1738-44. PubMed ID: 12039485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality.
    Brener SJ; Lytle BW; Schneider JP; Ellis SG; Topol EJ
    J Am Coll Cardiol; 2002 Dec; 40(11):1961-7. PubMed ID: 12475456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of peak troponin T and creatine kinase-MB elevations after percutaneous coronary intervention.
    Miller WL; Garratt KN; Burritt MF; Reeder GS; Jaffe AS
    Chest; 2004 Jan; 125(1):275-80. PubMed ID: 14718451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy.
    Ellis SG; Chew D; Chan A; Whitlow PL; Schneider JP; Topol EJ
    Circulation; 2002 Sep; 106(10):1205-10. PubMed ID: 12208794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of recurrent episodes of creatine kinase-MB elevation following repeated catheter-based coronary interventions.
    Kornowski R; Fuchs S; Hong MK; Mehran R; Satler LF; Pichard AD; Kent KM; Stone GW; Leon MB
    Catheter Cardiovasc Interv; 2000 Oct; 51(2):131-7. PubMed ID: 11025563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the prognostic value of peak creatine kinase-MB and troponin levels among patients with acute myocardial infarction: a report from the Acute Coronary Treatment and Intervention Outcomes Network Registry-get with the guidelines.
    Chin CT; Wang TY; Li S; Wiviott SD; deLemos JA; Kontos MC; Peterson ED; Roe MT
    Clin Cardiol; 2012; 35(7):424-9. PubMed ID: 22434769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term survival after major vascular surgery.
    Landesberg G; Shatz V; Akopnik I; Wolf YG; Mayer M; Berlatzky Y; Weissman C; Mosseri M
    J Am Coll Cardiol; 2003 Nov; 42(9):1547-54. PubMed ID: 14607436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations between cardiac troponin I, cardiac troponin T, and creatine phosphokinase MB elevation following successful percutaneous coronary intervention and prognostic value of each marker.
    Okmen E; Kasikcioglu H; Sanli A; Uyarel H; Cam N
    J Invasive Cardiol; 2005 Feb; 17(2):63-7. PubMed ID: 15687525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.